Sulodexide in Controlling the Recurrence of Psoriasis
Status:
ENROLLING_BY_INVITATION
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blindedcontrolled clinical trial. The purpose of the study is to evaluate the efficacy and safety of Sulodexide versus placebo in preventing psoriasis recurrence in patients with plaque psoriasis who have discontinued biologic therapy after achieving clinical cure.